Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MKNK2 | Human | (+)-schisandrin B | multiple interactions | ISO | Mknk2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MKNK2 mRNA] | CTD | PMID:31150632 | MKNK2 | Human | (-)-demecolcine | increases expression | EXP | | 6480464 | Demecolcine results in increased expression of MKNK2 mRNA | CTD | PMID:23649840 | MKNK2 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Mknk2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MKNK2 mRNA | CTD | PMID:36331819 | MKNK2 | Human | 1,2-dichloroethane | decreases expression | ISO | Mknk2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of MKNK2 mRNA | CTD | PMID:28189721 and PMID:28960355 | MKNK2 | Human | 1-naphthyl isothiocyanate | increases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of MKNK2 mRNA | CTD | PMID:30723492 | MKNK2 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of MKNK2 mRNA | CTD | PMID:17942748 | MKNK2 | Human | 17beta-estradiol | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Estradiol results in increased expression of MKNK2 mRNA | CTD | PMID:15289156 | MKNK2 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of MKNK2 mRNA | CTD | PMID:31614463 | MKNK2 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of MKNK2 mRNA | CTD | PMID:30165855 | MKNK2 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of MKNK2 mRNA | CTD | PMID:23019147 | MKNK2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MKNK2 mRNA | CTD | PMID:21215274 | MKNK2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mknk2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MKNK2 mRNA | CTD | PMID:21570461 | MKNK2 | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of MKNK2 mRNA | CTD | PMID:30851411 | MKNK2 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Mknk2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of MKNK2 mRNA | CTD | PMID:20188158 | MKNK2 | Human | 4,4'-sulfonyldiphenol | decreases expression | ISO | Mknk2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of MKNK2 mRNA | CTD | PMID:33297965 | MKNK2 | Human | 5-aza-2'-deoxycytidine | affects expression | EXP | | 6480464 | Decitabine affects the expression of MKNK2 mRNA | CTD | PMID:23300844 | MKNK2 | Human | amitrole | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of MKNK2 mRNA | CTD | PMID:38685447 | MKNK2 | Human | amosite asbestos | decreases methylation | EXP | | 6480464 | Asbestos and Amosite results in decreased methylation of MKNK2 promoter | CTD | PMID:29626692 | MKNK2 | Human | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA | CTD | PMID:32525701 | MKNK2 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA | CTD | PMID:32525701 | MKNK2 | Human | arsenous acid | decreases response to substance | EXP | | 6480464 | MKNK2 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:18299328 | MKNK2 | Human | arsenous acid | multiple interactions | EXP | | 6480464 | Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein more ... | CTD | PMID:18299328 | MKNK2 | Human | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of MKNK2 mRNA | CTD | PMID:22378314 | MKNK2 | Human | atrazine | affects methylation | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of MKNK2 gene | CTD | PMID:35440735 | MKNK2 | Human | benzo[a]pyrene | multiple interactions | ISO | Mknk2 (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to MKNK2 promoter] | CTD | PMID:19654925 | MKNK2 | Human | benzo[e]pyrene | decreases methylation | EXP | | 6480464 | benzo(e)pyrene results in decreased methylation of MKNK2 3' UTR | CTD | PMID:30157460 | MKNK2 | Human | beta-lapachone | increases expression | EXP | | 6480464 | beta-lapachone results in increased expression of MKNK2 mRNA | CTD | PMID:38218311 | MKNK2 | Human | beta-naphthoflavone | multiple interactions | ISO | Mknk2 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MKNK2 mRNA | CTD | PMID:18164116 | MKNK2 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MKNK2 mRNA | CTD | PMID:25047013 and PMID:29275510 | MKNK2 | Human | bisphenol A | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of MKNK2 mRNA | CTD | PMID:32156529 | MKNK2 | Human | bisphenol A | increases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of MKNK2 mRNA | CTD | PMID:34947998 | MKNK2 | Human | bisphenol A | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MKNK2 mRNA | CTD | PMID:32145629 | MKNK2 | Human | bisphenol A | affects expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of MKNK2 mRNA | CTD | PMID:25181051 | MKNK2 | Human | bromobenzene | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | bromobenzene results in decreased expression of MKNK2 mRNA | CTD | PMID:32479839 | MKNK2 | Human | cadmium dichloride | decreases methylation | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased methylation of MKNK2 promoter | CTD | PMID:22457795 | MKNK2 | Human | camptothecin | increases expression | EXP | | 6480464 | Camptothecin results in increased expression of MKNK2 mRNA | CTD | PMID:38460933 | MKNK2 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of MKNK2 mRNA | CTD | PMID:24752500 | MKNK2 | Human | carbon nanotube | decreases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | MKNK2 | Human | chlordecone | decreases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Chlordecone results in decreased expression of MKNK2 mRNA | CTD | PMID:33711761 | MKNK2 | Human | chlorpyrifos | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of MKNK2 mRNA | CTD | PMID:37019170 | MKNK2 | Human | ciguatoxin CTX1B | affects expression | ISO | Mknk2 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of MKNK2 mRNA | CTD | PMID:18353800 | MKNK2 | Human | cisplatin | increases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Cisplatin results in increased expression of MKNK2 mRNA | CTD | PMID:21993003 | MKNK2 | Human | cisplatin | affects expression | EXP | | 6480464 | Cisplatin affects the expression of MKNK2 mRNA | CTD | PMID:23300844 | MKNK2 | Human | cisplatin | multiple interactions | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Oxytocin inhibits the reaction [Cisplatin results in increased expression of MKNK2 mRNA] | CTD | PMID:21993003 | MKNK2 | Human | clofibrate | decreases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of MKNK2 mRNA | CTD | PMID:17585979 | MKNK2 | Human | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of MKNK2 mRNA | CTD | PMID:19376846 | MKNK2 | Human | copper atom | multiple interactions | EXP | | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of MKNK2 mRNA | CTD | PMID:30911355 | MKNK2 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of MKNK2 mRNA | CTD | PMID:30911355 | MKNK2 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of MKNK2 mRNA | CTD | PMID:19549813 | MKNK2 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA | CTD | PMID:19167446 | MKNK2 | Human | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of MKNK2 mRNA | CTD | PMID:19167446 | MKNK2 | Human | crocidolite asbestos | decreases methylation | EXP | | 6480464 | Asbestos and Crocidolite results in decreased methylation of MKNK2 promoter | CTD | PMID:29626692 | MKNK2 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of MKNK2 mRNA | CTD | PMID:25562108 and PMID:27989131 | MKNK2 | Human | deoxynivalenol | affects phosphorylation | ISO | Mknk2 (Mus musculus) | 6480464 | deoxynivalenol affects the phosphorylation of MKNK2 protein | CTD | PMID:23811945 | MKNK2 | Human | deoxynivalenol | decreases expression | EXP | | 6480464 | deoxynivalenol results in decreased expression of MKNK2 mRNA | CTD | PMID:31863870 | MKNK2 | Human | dexamethasone | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of MKNK2 mRNA | CTD | PMID:22733784 | MKNK2 | Human | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of MKNK2 mRNA | CTD | PMID:25047013 | MKNK2 | Human | diarsenic trioxide | decreases response to substance | EXP | | 6480464 | MKNK2 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:18299328 | MKNK2 | Human | diarsenic trioxide | multiple interactions | EXP | | 6480464 | Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein more ... | CTD | PMID:18299328 | MKNK2 | Human | dibenz[a,h]anthracene | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | MKNK2 | Human | diclofenac | affects expression | EXP | | 6480464 | Diclofenac affects the expression of MKNK2 mRNA | CTD | PMID:24752500 | MKNK2 | Human | diethyl maleate | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | diethyl maleate results in decreased expression of MKNK2 mRNA | CTD | PMID:21161181 | MKNK2 | Human | diethylstilbestrol | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Diethylstilbestrol results in increased expression of MKNK2 mRNA | CTD | PMID:15289156 | MKNK2 | Human | dioxygen | multiple interactions | ISO | Mknk2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MKNK2 mRNA | CTD | PMID:30529165 | MKNK2 | Human | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of MKNK2 mRNA | CTD | PMID:20042640 | MKNK2 | Human | diquat | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Diquat results in increased expression of MKNK2 mRNA | CTD | PMID:36851058 | MKNK2 | Human | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of MKNK2 mRNA | CTD | PMID:24383545 | MKNK2 | Human | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA | CTD | PMID:19167446 | MKNK2 | Human | epoxiconazole | decreases expression | ISO | Mknk2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of MKNK2 mRNA | CTD | PMID:35436446 | MKNK2 | Human | ethanol | decreases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Ethanol results in decreased expression of MKNK2 mRNA | CTD | PMID:15513904 | MKNK2 | Human | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of MKNK2 protein | CTD | PMID:37730182 | MKNK2 | Human | furan | increases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | furan results in increased expression of MKNK2 mRNA | CTD | PMID:26194646 | MKNK2 | Human | genistein | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Genistein results in increased expression of MKNK2 mRNA | CTD | PMID:15289156 | MKNK2 | Human | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of MKNK2 mRNA | CTD | PMID:22228119 | MKNK2 | Human | glyphosate | increases expression | EXP | | 6480464 | Glyphosate results in increased expression of MKNK2 mRNA | CTD | PMID:31295307 | MKNK2 | Human | isoprenaline | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of MKNK2 mRNA | CTD | PMID:20003209 | MKNK2 | Human | lead diacetate | decreases expression | ISO | Mknk2 (Mus musculus) | 6480464 | lead acetate results in decreased expression of MKNK2 mRNA | CTD | PMID:25270620 | MKNK2 | Human | methapyrilene | decreases methylation | EXP | | 6480464 | Methapyrilene results in decreased methylation of MKNK2 3' UTR | CTD | PMID:30157460 | MKNK2 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Mknk2 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MKNK2 mRNA | CTD | PMID:18164116 | MKNK2 | Human | nefazodone | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | nefazodone results in decreased expression of MKNK2 mRNA | CTD | PMID:24136188 | MKNK2 | Human | niclosamide | increases expression | EXP | | 6480464 | Niclosamide results in increased expression of MKNK2 mRNA | CTD | PMID:36318118 | MKNK2 | Human | Nor-9-carboxy-delta9-THC | multiple interactions | EXP | | 6480464 | [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MKNK2 gene | CTD | PMID:30521419 | MKNK2 | Human | orphenadrine | affects expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Orphenadrine affects the expression of MKNK2 mRNA | CTD | PMID:23665939 | MKNK2 | Human | oxytocin | multiple interactions | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Oxytocin inhibits the reaction [Cisplatin results in increased expression of MKNK2 mRNA] | CTD | PMID:21993003 | MKNK2 | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of MKNK2 mRNA | CTD | PMID:35430440 | MKNK2 | Human | p-toluidine | increases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | 4-toluidine results in increased expression of MKNK2 mRNA | CTD | PMID:27638505 | MKNK2 | Human | paracetamol | affects expression | ISO | Mknk2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of MKNK2 mRNA | CTD | PMID:15606129 and PMID:17562736 | MKNK2 | Human | paracetamol | increases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of MKNK2 mRNA | CTD | PMID:33387578 | MKNK2 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MKNK2 mRNA | CTD | PMID:21420995 and PMID:29067470 | MKNK2 | Human | parathion | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Parathion results in increased expression of MKNK2 mRNA | CTD | PMID:34813904 | MKNK2 | Human | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of MKNK2 mRNA | CTD | PMID:32588087 | MKNK2 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Mknk2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MKNK2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MKNK2 mRNA | CTD | PMID:36331819 | MKNK2 | Human | phenformin | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Phenformin results in decreased expression of MKNK2 mRNA | CTD | PMID:31324951 | MKNK2 | Human | phenobarbital | multiple interactions | ISO | Mknk2 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MKNK2 mRNA] | CTD | PMID:19482888 | MKNK2 | Human | phenobarbital | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of MKNK2 mRNA | CTD | PMID:19270015 and PMID:19482888 | MKNK2 | Human | PhIP | increases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of MKNK2 mRNA | CTD | PMID:15215175 | MKNK2 | Human | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of MKNK2 mRNA | CTD | PMID:18037150 | MKNK2 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of MKNK2 mRNA | CTD | PMID:21632981 | MKNK2 | Human | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of MKNK2 mRNA | CTD | PMID:30152185 | MKNK2 | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of MKNK2 mRNA | CTD | PMID:30851411 | MKNK2 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of MKNK2 mRNA | CTD | PMID:23557933 | MKNK2 | Human | rotenone | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of MKNK2 mRNA | CTD | PMID:28374803 | MKNK2 | Human | serpentine asbestos | decreases methylation | EXP | | 6480464 | Asbestos and Serpentine results in decreased methylation of MKNK2 promoter | CTD | PMID:29626692 | MKNK2 | Human | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA | CTD | PMID:32525701 | MKNK2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MKNK2 mRNA | CTD | PMID:28595984 | MKNK2 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of MKNK2 mRNA | CTD | PMID:38568856 | MKNK2 | Human | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of MKNK2 mRNA | CTD | PMID:29319823 and PMID:34032870 | MKNK2 | Human | streptozocin | increases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Streptozocin results in increased expression of MKNK2 mRNA | CTD | PMID:25905778 | MKNK2 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of MKNK2 mRNA | CTD | PMID:31533062 | MKNK2 | Human | T-2 toxin | decreases expression | EXP | | 6480464 | T-2 Toxin results in decreased expression of MKNK2 mRNA | CTD | PMID:31863870 | MKNK2 | Human | tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of MKNK2 mRNA | CTD | PMID:15336504 | MKNK2 | Human | tert-butyl hydroperoxide | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | tert-Butylhydroperoxide results in increased expression of MKNK2 mRNA | CTD | PMID:15003993 | MKNK2 | Human | tetrachloromethane | multiple interactions | ISO | Mknk2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MKNK2 mRNA] | CTD | PMID:31150632 | MKNK2 | Human | tetrachloromethane | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of MKNK2 mRNA | CTD | PMID:31919559 | MKNK2 | Human | tetrachloromethane | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of MKNK2 mRNA | CTD | PMID:31150632 | MKNK2 | Human | thioacetamide | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of MKNK2 mRNA | CTD | PMID:34492290 | MKNK2 | Human | thiram | increases expression | EXP | | 6480464 | Thiram results in increased expression of MKNK2 mRNA | CTD | PMID:38568856 | MKNK2 | Human | titanium dioxide | decreases methylation | ISO | Mknk2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of MKNK2 promoter | CTD | PMID:35295148 | MKNK2 | Human | topotecan | affects response to substance | EXP | | 6480464 | MKNK2 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | MKNK2 | Human | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of MKNK2 mRNA | CTD | PMID:28542535 | MKNK2 | Human | triphenyl phosphate | affects expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | triphenyl phosphate affects the expression of MKNK2 mRNA | CTD | PMID:30589522 | MKNK2 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of MKNK2 mRNA | CTD | PMID:37042841 | MKNK2 | Human | triptonide | increases expression | ISO | Mknk2 (Mus musculus) | 6480464 | triptonide results in increased expression of MKNK2 mRNA | CTD | PMID:33045310 | MKNK2 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of MKNK2 mRNA | CTD | PMID:28818685 | MKNK2 | Human | valdecoxib | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | valdecoxib results in decreased expression of MKNK2 mRNA | CTD | PMID:24136188 | MKNK2 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of MKNK2 gene | CTD | PMID:29154799 | MKNK2 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of MKNK2 mRNA | CTD | PMID:25979313 | MKNK2 | Human | vinclozolin | decreases expression | ISO | Mknk2 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of MKNK2 mRNA | CTD | PMID:23034163 | MKNK2 | Human | vincristine | increases expression | EXP | | 6480464 | Vincristine results in increased expression of MKNK2 mRNA | CTD | PMID:23649840 | MKNK2 | Human | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of MKNK2 mRNA | CTD | PMID:27188386 | |